Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00000102 |
Recruitment Status
:
Completed
First Posted
: November 4, 1999
Last Update Posted
: June 24, 2005
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Congenital Adrenal Hyperplasia | Drug: Nifedipine | Phase 1 Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Intervention Model: | Parallel Assignment |
Masking: | Double |
Primary Purpose: | Treatment |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 14 Years to 35 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- diagnosed with Congenital Adrenal Hyperplasia (CAH)
- normal ECG during baseline evaluation
Exclusion Criteria:
- history of liver disease, or elevated liver function tests
- history of cardiovascular disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00000102
United States, South Carolina | |
Medical University of South Carolina | |
Charleston, South Carolina, United States |
ClinicalTrials.gov Identifier: | NCT00000102 History of Changes |
Other Study ID Numbers: |
NCRR-M01RR01070-0506 M01RR001070 ( U.S. NIH Grant/Contract ) |
First Posted: | November 4, 1999 Key Record Dates |
Last Update Posted: | June 24, 2005 |
Last Verified: | January 2004 |
Additional relevant MeSH terms:
Hyperplasia Adrenal Hyperplasia, Congenital Adrenogenital Syndrome Adrenocortical Hyperfunction Pathologic Processes Disorders of Sex Development Urogenital Abnormalities Congenital Abnormalities Genetic Diseases, Inborn Steroid Metabolism, Inborn Errors Metabolism, Inborn Errors Metabolic Diseases |
Adrenal Gland Diseases Endocrine System Diseases Gonadal Disorders Nifedipine Calcium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Vasodilator Agents Tocolytic Agents Reproductive Control Agents Physiological Effects of Drugs |